Xeris Pharmaceuticals (XERS)
NASDAQ:XERS

Xeris Pharmaceuticals (XERS) Technical Analysis

902 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Xeris Pharmaceuticals’s (XERS) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Xeris Pharmaceuticals is a Sell.
Xeris Pharmaceuticals’s (XERS) 20-Day exponential moving average is 2.19, while Xeris Pharmaceuticals’s (XERS) share price is $2.48, making it a Buy.
Xeris Pharmaceuticals’s (XERS) 50-Day exponential moving average is 2.15, while Xeris Pharmaceuticals’s (XERS) share price is $2.48, making it a Buy.

Xeris Pharmaceuticals (XERS) Pivot Points

Jul 30, 2024, 03:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.00
2.10
2.22
2.32
2.44
2.53
2.65
Fibonacci
2.10
2.18
2.23
2.32
2.40
2.45
2.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xeris Pharmaceuticals (XERS) Moving Averages

Jul 30, 2024, 03:35 AM
Period
Simple
Exponential
MA5
2.23Buy
2.26Buy
MA10
2.18Buy
2.21Buy
MA20
2.17Buy
2.19Buy
MA50
2.10Buy
2.15Buy
MA100
2.18Buy
2.16Buy
MA200
2.14Buy
2.16Buy
Xeris Pharmaceuticals’s (XERS) 10-Day exponential moving average is 2.21, while Xeris Pharmaceuticals’s (XERS) share price is $2.48, making it a Buy.
Xeris Pharmaceuticals’s (XERS) 100-Day exponential moving average is 2.16, while Xeris Pharmaceuticals’s (XERS) share price is $2.48, making it a Buy.
Xeris Pharmaceuticals’s (XERS) stock price is $2.48 and Xeris Pharmaceuticals’s (XERS) 50-day simple moving average is 2.10, creating a Buy signal.
Xeris Pharmaceuticals’s (XERS) stock price is $2.48 and Xeris Pharmaceuticals’s (XERS) 100-day simple moving average is 2.18, creating a Buy signal.
Xeris Pharmaceuticals’s (XERS) stock price is $2.48 and Xeris Pharmaceuticals’s (XERS) 200-day simple moving average is 2.14, creating a Buy signal.

Xeris Pharmaceuticals (XERS) Technical Indicators

Jul 30, 2024, 03:35 AM
Name
Value
Implied Action
RSI (14)
64.35
Neutral
STOCH (9,6)
71.13
Neutral
STOCHRSI (14)
71.13
Neutral
MACD (12,26)
0.03
Sell
ADX (14)
26.22
Neutral
Williams %R
-13.16
Sell
CCI (14)
202.16
Sell
ATR (14)
0.12
-
Ultimate Oscillator
53.32
Neutral
ROC
11.85
Buy
Xeris Pharmaceuticals’s (XERS) Relative Strength Index (RSI) is 64.35, creating a Neutral signal.
Xeris Pharmaceuticals’s (XERS) Trend Strength Indicator (ADX) is 26.22, creating a Neutral signal.
Xeris Pharmaceuticals’s (XERS) Commodity Channel Index (CCI) is 202.16, creating a Sell signal.
Xeris Pharmaceuticals’s (XERS) Price Rate of Change (ROC) is 11.85, creating a Buy signal.

FAQ

Is XERS a Buy, Hold, or Sell?
Based on XERS’s technical indicators, XERS is a Buy.
    What is XERS’s RSI (14)?
    XERS’s RSI (14) is 64.35, which suggests XERS is a Neutral.
      What is XERS’s MACD?
      XERS’s MACD is 0.03, which suggests XERS is a Sell.
        What is XERS’s 5-day moving average?
        XERS’s 5-day moving average is 2.23, which suggests XERS is a Buy.
          What is XERS’s 20-day moving average?
          XERS 20-day moving average is 2.17, which suggests XERS is a Buy.
            What is XERS’s 50-day moving average?
            XERS’s 50-day moving average is 2.10, which suggests XERS is a Buy.
              What is XERS’s 200-day moving average?
              XERS’s 200-day moving average is 2.14, which suggests XERS is a Buy.
                What is XERS’s Williams % R (14)?
                XERS’s Williams % R (14) is -13.16, which suggests XERS is a Sell.
                  What is XERS’s CCI (14)?
                  XERS’s CCI (14) is 202.16, which suggests XERS is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis